Ausbil Investment Management Ltd Purchases Shares of 1,351 Chemed Co. (NYSE:CHE)

Ausbil Investment Management Ltd purchased a new stake in Chemed Co. (NYSE:CHEFree Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 1,351 shares of the company’s stock, valued at approximately $732,000.

A number of other institutional investors and hedge funds have also made changes to their positions in CHE. Janiczek Wealth Management LLC raised its holdings in shares of Chemed by 309.1% in the 1st quarter. Janiczek Wealth Management LLC now owns 45 shares of the company’s stock worth $25,000 after purchasing an additional 34 shares during the period. Nelson Van Denburg & Campbell Wealth Management Group LLC increased its position in shares of Chemed by 400.0% in the first quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 75 shares of the company’s stock worth $40,000 after acquiring an additional 60 shares in the last quarter. Altshuler Shaham Ltd raised its stake in shares of Chemed by 60.8% in the 1st quarter. Altshuler Shaham Ltd now owns 82 shares of the company’s stock valued at $44,000 after acquiring an additional 31 shares during the period. Canada Pension Plan Investment Board acquired a new position in shares of Chemed during the 1st quarter valued at $46,000. Finally, Benjamin Edwards Inc. increased its holdings in Chemed by 98.0% in the 1st quarter. Benjamin Edwards Inc. now owns 99 shares of the company’s stock valued at $53,000 after purchasing an additional 49 shares in the last quarter. 94.25% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Chemed

In related news, CEO Kevin J. Mcnamara sold 4,000 shares of the business’s stock in a transaction dated Thursday, August 3rd. The shares were sold at an average price of $516.43, for a total transaction of $2,065,720.00. Following the completion of the sale, the chief executive officer now owns 115,571 shares of the company’s stock, valued at approximately $59,684,331.53. The sale was disclosed in a legal filing with the SEC, which is available through this link. 4.03% of the stock is owned by insiders.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on the company. Royal Bank of Canada lowered their target price on Chemed from $610.00 to $576.00 and set an “outperform” rating for the company in a research note on Monday, July 31st. upgraded shares of Chemed from a “hold” rating to a “buy” rating in a research note on Wednesday, August 30th.

View Our Latest Stock Analysis on Chemed

Chemed Trading Down 0.4 %

NYSE CHE traded down $2.13 during mid-day trading on Monday, reaching $510.13. 7,080 shares of the company’s stock traded hands, compared to its average volume of 71,032. The company has a market cap of $7.69 billion, a price-to-earnings ratio of 34.01, a P/E/G ratio of 3.04 and a beta of 0.53. The company has a fifty day simple moving average of $519.70 and a 200-day simple moving average of $532.42. Chemed Co. has a 1-year low of $430.16 and a 1-year high of $574.66.

Chemed (NYSE:CHEGet Free Report) last posted its quarterly earnings data on Wednesday, July 26th. The company reported $4.71 EPS for the quarter, missing analysts’ consensus estimates of $5.09 by ($0.38). Chemed had a net margin of 10.36% and a return on equity of 34.65%. The company had revenue of $553.80 million for the quarter, compared to the consensus estimate of $562.54 million. During the same quarter last year, the company earned $4.84 earnings per share. The company’s revenue was up 4.2% compared to the same quarter last year. Equities research analysts forecast that Chemed Co. will post 19.14 earnings per share for the current fiscal year.

Chemed Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 5th. Shareholders of record on Monday, August 14th were issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.31%. The ex-dividend date was Friday, August 11th. This is an increase from Chemed’s previous quarterly dividend of $0.38. Chemed’s payout ratio is currently 10.67%.

Chemed Company Profile

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Recommended Stories

Want to see what other hedge funds are holding CHE? Visit to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHEFree Report).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with's FREE daily email newsletter.